The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
[4-(5-Aminothiazolo[5,4-d]pyrimidin-7-yl)piperazin-1-yl]-(1H-indol-2-yl)methanone ID: ALA4218178
PubChem CID: 145969385
Max Phase: Preclinical
Molecular Formula: C18H17N7OS
Molecular Weight: 379.45
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: Nc1nc(N2CCN(C(=O)c3cc4ccccc4[nH]3)CC2)c2ncsc2n1
Standard InChI: InChI=1S/C18H17N7OS/c19-18-22-15(14-16(23-18)27-10-20-14)24-5-7-25(8-6-24)17(26)13-9-11-3-1-2-4-12(11)21-13/h1-4,9-10,21H,5-8H2,(H2,19,22,23)
Standard InChI Key: WPPOSOGWMNQIDJ-UHFFFAOYSA-N
Molfile:
RDKit 2D
27 31 0 0 0 0 0 0 0 0999 V2000
29.8632 -23.0258 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
29.8621 -23.8453 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.5701 -24.2543 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
30.5683 -22.6169 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.2769 -23.0222 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.2818 -23.8453 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.0661 -24.0952 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
32.5461 -23.4263 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.0583 -22.7633 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
29.1540 -24.2533 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
30.5659 -21.7997 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
31.2743 -21.3897 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.2738 -20.5761 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.5667 -20.1658 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
29.8584 -20.5753 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.8572 -21.3951 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.5673 -19.3486 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.8599 -18.9394 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
31.2723 -18.9384 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.0185 -19.2713 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
31.3584 -18.1258 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.1578 -17.9564 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.5633 -18.6645 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.3748 -18.6673 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.7869 -17.9637 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.3814 -17.2556 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.5637 -17.2511 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
6 7 1 0
7 8 1 0
8 9 2 0
9 5 1 0
2 10 1 0
4 11 1 0
11 12 1 0
11 16 1 0
12 13 1 0
13 14 1 0
14 15 1 0
15 16 1 0
14 17 1 0
17 18 2 0
19 20 1 0
20 23 1 0
22 21 1 0
21 19 2 0
17 19 1 0
22 23 2 0
22 27 1 0
23 24 1 0
24 25 2 0
25 26 1 0
26 27 2 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 379.45Molecular Weight (Monoisotopic): 379.1215AlogP: 2.11#Rotatable Bonds: 2Polar Surface Area: 104.03Molecular Species: NEUTRALHBA: 7HBD: 2#RO5 Violations: ┄HBA (Lipinski): 8HBD (Lipinski): 3#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 4.35CX LogP: 2.06CX LogD: 2.06Aromatic Rings: 4Heavy Atoms: 27QED Weighted: 0.55Np Likeness Score: -1.50
References 1. Reuberson J, Horsley H, Franklin RJ, Ford D, Neuss J, Brookings D, Huang Q, Vanderhoydonck B, Gao LJ, Jang MY, Herdewijn P, Ghawalkar A, Fallah-Arani F, Khan AR, Henshall J, Jairaj M, Malcolm S, Ward E, Shuttleworth L, Lin Y, Li S, Louat T, Waer M, Herman J, Payne A, Ceska T, Doyle C, Pitt W, Calmiano M, Augustin M, Steinbacher S, Lammens A, Allen R.. (2018) Discovery of a Potent, Orally Bioavailable PI4KIIIβ Inhibitor (UCB9608) Able To Significantly Prolong Allogeneic Organ Engraftment in Vivo., 61 (15): [PMID:29952567 ] [10.1021/acs.jmedchem.8b00521 ]